NEUPATHS
Live / Applied — Third extension granted (statement of use) (as of 05 Nov 2025)
What this means for you
Not registered yet, but its 14 Jun 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98041733
- Mark type
- Stylized text
- Filed
- 14 Jun 2023
- Published for opposition
- 02 Apr 2024
- Attorney of record
- Scott D. Woldow
Goods and services
- Class 041 — Education and entertainment services: Educational services, namely, providing presentations and non-downloadable electronic manuals in the field of health and treatment; Publication of journals, periodicals, articles, and other printed matter of the results of clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions, and immunological conditions play an important role in pathogenesis
- Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions, and immunological conditions play an important role in pathogenesis
- Class 044 — Medical, beauty and agricultural services: Providing medical information and treatment information for clinical trials for diseases with strong evidence of neutrophil driven pathophysiology, chronic inflammatory diseases, Hidradenitis Suppurative (HS), and potentially Palmoplantar Pustulosis (PPP), in which neutrophil proliferation, differentiation, release, migration, function and survival, inflammatory conditions and immunological conditions play an important role in pathogenesis
Owner
- CSL Behring L.L.C., King of Prussia, PA, US
- CSL Behring L.L.C., King of Prussia, PA, US
Prosecution history
- 06 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Nov 2025 — SOU EXTENSION 3 GRANTED
- 05 Nov 2025 — SOU EXTENSION 3 FILED
- 05 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 07 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 May 2025 — SOU EXTENSION 2 GRANTED
- 07 May 2025 — SOU EXTENSION 2 FILED
- 07 May 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Nov 2024 — SOU EXTENSION 1 GRANTED
- 05 Nov 2024 — SOU EXTENSION 1 FILED
- 05 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 04 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Apr 2024 — PUBLISHED FOR OPPOSITION